aztreonam has been researched along with Pelvic Inflammatory Disease in 4 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Pelvic Inflammatory Disease: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-two patients with acute pelvic inflammatory disease were treated using aztreonam, a monobactam, and clindamycin." | 7.67 | Treatment of acute pelvic inflammatory disease with aztreonam, a new monocyclic beta-lactam antibiotic, and clindamycin. ( Dodson, MG; Faro, S; Gentry, LO, 1986) |
| "Forty-two patients with acute pelvic inflammatory disease were treated using aztreonam, a monobactam, and clindamycin." | 3.67 | Treatment of acute pelvic inflammatory disease with aztreonam, a new monocyclic beta-lactam antibiotic, and clindamycin. ( Dodson, MG; Faro, S; Gentry, LO, 1986) |
| "Aztreonam, a new monobactam antibiotic with specific gram-negative aerobic activity, was used in combination with clindamycin in the treatment of 40 women with pelvic infection, including post-partum endometritis, pelvic inflammatory disease, and post-hysterectomy pelvic cellulitis." | 3.67 | Aztreonam plus clindamycin as therapy for pelvic infections in women. ( Aldridge, KE; Cole, C; Crapanzano, JC; Pastorek, JG, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodson, MG | 2 |
| Chimura, T | 1 |
| Ise, H | 1 |
| Misawa, H | 1 |
| Faro, S | 1 |
| Gentry, LO | 1 |
| Pastorek, JG | 1 |
| Cole, C | 1 |
| Aldridge, KE | 1 |
| Crapanzano, JC | 1 |
1 review available for aztreonam and Pelvic Inflammatory Disease
| Article | Year |
|---|---|
Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation.
Topics: Acute Disease; Anti-Bacterial Agents; Aztreonam; Cefotetan; Cefoxitin; Chlamydia Infections; Chlamyd | 1994 |
3 other studies available for aztreonam and Pelvic Inflammatory Disease
| Article | Year |
|---|---|
[In vitro study on efficacy of combination use of aspoxicillin and beta-lactam preparations (ceftazidime, cefmetazole and aztreonam) against bacteria isolated from abdominal infections].
Topics: Amoxicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; beta-Lactamases; Bili | 1992 |
Treatment of acute pelvic inflammatory disease with aztreonam, a new monocyclic beta-lactam antibiotic, and clindamycin.
Topics: Adult; Aztreonam; Body Temperature; Cervix Uteri; Clindamycin; Drug Evaluation; Drug Therapy, Combin | 1986 |
Aztreonam plus clindamycin as therapy for pelvic infections in women.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Th | 1985 |